- Home
- Publications
- Publication Search
- Publication Details
Title
Chances and risks of SGLT2 inhibitors
Authors
Keywords
-
Journal
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
Volume 385, Issue 6, Pages 551-554
Publisher
Springer Nature
Online
2012-01-04
DOI
10.1007/s00210-011-0720-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of SGLT2: A Novel Strategy for Treatment of Type 2 Diabetes Mellitus
- (2011) M Pfister et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Kidney in Diabetes: from Organ Damage Target to Therapeutic Target
- (2011) Teresa Salvatore et al. CURRENT DRUG METABOLISM
- Sodium-Glucose Co-Transporter 2 Inhibitors: From Apple Tree to ‘Sweet Pee’
- (2011) Timothy C. Hardman et al. CURRENT PHARMACEUTICAL DESIGN
- Development of Sodium-Dependent Glucose Co-Transporter 2 Inhibitors as Potential Anti-Diabetic Therapeutics
- (2011) Low-Tone Ho et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin: A randomized, 52-week, double-blind, active-controlled noninferiority trial
- (2011) M. A. Nauck et al. DIABETES CARE
- Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24-week, double-blind, placebo-controlled trial
- (2011) K. Strojek et al. DIABETES OBESITY & METABOLISM
- Diabetes field cautiously upbeat despite possible setback for leading SGLT2 inhibitor
- (2011) Dan Jones NATURE REVIEWS DRUG DISCOVERY
- A New Approach to Glucose Control in Type 2 Diabetes: The Role of Kidney Sodium-Glucose Co-transporter 2 Inhibition
- (2011) Jan Basile POSTGRADUATE MEDICINE
- Renal glucose reabsorption inhibitors to treat diabetes
- (2011) Clifford J. Bailey TRENDS IN PHARMACOLOGICAL SCIENCES
- Dapagliflozin Monotherapy in Type 2 Diabetic Patients With Inadequate Glycemic Control by Diet and Exercise: A randomized, double-blind, placebo-controlled, phase 3 trial
- (2010) E. Ferrannini et al. DIABETES CARE
- Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial
- (2010) Clifford J Bailey et al. LANCET
- SGLT2 inhibition — a novel strategy for diabetes treatment
- (2010) Edward C. Chao et al. NATURE REVIEWS DRUG DISCOVERY
- The Barrier of Hypoglycemia in Diabetes
- (2008) P. E. Cryer DIABETES
- 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
- (2008) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now